Market Place
Sourcing Support
All News #Library
Biotech
Day One Completes Acquisition Of Mersana Therapeutics
06 Jan 2026 //
GLOBENEWSWIRE
Mersana Therapeutics Hosts Q3 2025 Conference Call On Nov 14
10 Nov 2025 //
GLOBENEWSWIRE
Mersana lays off 55% of staff, narrows focus to B7-H4 ADC
07 May 2025 //
GLOBENEWSWIRE
Mersana Therapeutics to Present Emi-Le at ASCO 2025 Meeting
23 Apr 2025 //
GLOBENEWSWIRE
Mersana Therapeutics to Present Emi-Le Data at ESMO 2025
01 Apr 2025 //
GLOBENEWSWIRE
Mersana Therapeutics to Present at Upcoming Investor Conferences
25 Feb 2025 //
GLOBENEWSWIRE
Mersana Therapeutics to Host Q4 2024 Conference Call on March 3
24 Feb 2025 //
GLOBENEWSWIRE
Mersana Announces Inducement Grant Under Nasdaq LR 5635(c)(4)
07 Feb 2025 //
GLOBENEWSWIRE
Mersana Therapeutic to Participate in Guggenheim Biotech Conference
30 Jan 2025 //
GLOBENEWSWIRE
Mersana Reports Positive Ph 1 Data For XMT-1660 In TNBC Expansion
10 Jan 2025 //
GLOBENEWSWIRE
Mersana Gets FDA Fast Track Designation For Emiltatug Ledadotin
10 Jan 2025 //
GLOBENEWSWIRE
Mersana Therapeutics Reports Q2 2024 Results And Business Update
13 Aug 2024 //
GLOBENEWSWIRE
It`s a wrap for Merck KGaA and Mersana`s 2014 ADC pact
23 Dec 2023 //
FIERCE BIOTECH
Mersana Therapeutics Announces Third Quarter 2023 Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Mersana`s phase 1 ADC cancer trial breaks free of FDA hold
31 Oct 2023 //
FIERCE BIOTECH
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
08 Aug 2023 //
GLOBENEWSWIRE
Mersana Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Apr 2023 //
GLOBENEWSWIRE
Mersana Announces Initiation of PI Trial of XMT-2056 in HER2-Expressing Tumors
25 Jan 2023 //
GLOBENEWSWIRE
Mersana Provides Business Update and Announces Strategic Objectives
06 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.